Dengue vaccine development: challenges and prospects

Purpose of review - Dengue vaccine development is a high public health priority. To date, no dengue vaccine is in widespread use. Here we review the challenges in dengue development and the latest results for the second-generation dengue vaccines. - Recent findings - The biggest hurdle is th...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
1. Verfasser: Wilder-Smith, Annelies (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 2022
In: Current opinion in infectious diseases
Year: 2022, Jahrgang: 35, Heft: 5, Pages: 390-396
ISSN:1473-6527
DOI:10.1097/QCO.0000000000000871
Online-Zugang:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1097/QCO.0000000000000871
Verlag, lizenzpflichtig, Volltext: https://journals.lww.com/co-infectiousdiseases/Abstract/2022/10000/Dengue_vaccine_development__challenges_and.4.aspx
Volltext
Verfasserangaben:Annelies Wilder-Smith
Beschreibung
Zusammenfassung:Purpose of review - Dengue vaccine development is a high public health priority. To date, no dengue vaccine is in widespread use. Here we review the challenges in dengue development and the latest results for the second-generation dengue vaccines. - Recent findings - The biggest hurdle is the immunological interaction between the four antigenically distinct dengue serotypes. The advantages of second-generation dengue vaccines are the inclusion of nonstructural proteins of the dengue backbone and a more convenient dosing with reduced numbers of doses needed. - Summary - Although dengue-primed individuals can already benefit from vaccination with the first licensed dengue vaccine CYD-TDV, the public health need for the dengue-naive population has not yet been met. The urgent need remains to identify correlates of both protection and enhancement; until such correlates have been identified, all second-generation dengue vaccines still need to go through full phase 3 trials. The 5-year efficacy and safety data for both second-generation dengue vaccines are imminent.
Beschreibung:Gesehen am 11.10.2022
Beschreibung:Online Resource
ISSN:1473-6527
DOI:10.1097/QCO.0000000000000871